Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPH3127 in Diabetic Kidney Disease
NCT05593575Phase 2Completed
- Sponsor
- Shanghai Pharmaceuticals Holding Co Ltd
- Start
- Mar 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitokiren in diabetic kidney disease (DKD), sponsored by Shanghai Pharmaceuticals Holding Co Ltd. Started Mar 2023; status: completed.
02
Drugs
sitokiren
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT05593575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05593575.